Phlogenzym® in Patients With Acute Thrombophlebitis - Efficacy and Tolerance
NCT03470337
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Thrombophlebitis Leg
Interventions
DRUG:
Phlogenzym
OTHER:
Placebo
Sponsor
Mucos Pharma GmbH & Co. KG